Weill Cornell Medicine Oncology & Hematology


 

Management of R/R MCL: Ibrutinib and Acalabrutinib Data, Venetoclax Monotherapy, Combination Therapies & BTK Inhibitor AE Management

0 views
March 25, 2020
For the complete PeerView activity, and to receive CME credit or download slides and educational ...
read more ↘
Comments 0
Login to view comments. Click here to Login